SNPS
SynopsysNASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-05-08
As of May 8, 2026, SNPS has a composite score of 8.4 and a signal label of "mixed." The score reflects medium confidence at 74.8 and high market risk at 76.6. Key drivers include macroeconomic factors such as rates, growth, inflation, and labor, with recent guidance changes impacting the outlook. This assessment is provisional.
Price
Daily closes from AlphaVantage. Earnings/event dots are placed inline.
Factor signals
Read top-to-bottom: thesis (is this a strong company over a 1–3 year hold), watch flags (has something changed worth re-reading), and position context (how violent might the path be). Each pill is a parallel diagnostic — never aggregated into a single score.
Thesis
— is this a strong company over a 1–3 year hold?Why this rank
- Direction share1.00
- Slope (norm)-0.26
- Bonus0.00
Why this rank
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Why this rank
Watch
— has something changed worth re-reading?Buyback / dividend activity on weakening fundamentals — historically a value-trap pattern (48% T+1y positive return vs 69% baseline in IT 2024-26).
Why this setup
EPS estimate $3.63 → $3.63 (+0.0% / 30d). 2 raised, 13 cut, 17 covering analysts.
0 upgrades, 0 downgrades / 30d. 68% of analysts rate Buy.
0 positive, 0 negative / 30d.
F4 · Management deep-dive — recent events, stated priorities, guidance track record
Recent 8-K events
11 material events in the last 24 months — top 5 listed below.
Stated priorities
3 priorityies extracted from earnings transcripts (as of 2026-05-08).
- 1.Accelerated share repurchase programcapital allocationmixed44% progress
3/2: “Synopsys announced an accelerated share repurchase agreement to repurchase $250 million of shares.”
Why this status
Newly stated in 2026-Q1. Synopsys announced a $250 million accelerated share repurchase agreement. This is a new capital allocation initiative, and its impact on financials will be observed in future quarters.
- 2.Stock repurchase program authorizationcapital allocationon track77% progress
2/25: “The board authorized a stock repurchase program of up to $2 billion.”
Why this status
Newly stated in 2026-Q1. Synopsys authorized a stock repurchase program of up to $2 billion. This authorization provides flexibility for capital allocation, but its execution and impact on financials remain to be seen.
- 3.Revenue growth target for FY 2026growthmixed65% progress
2/25: “Reiterating expectations for full-year total revenue of $9.61 billion at the midpoint.”
Why this status
Stated in 2 of last 2 quarters. Revenue grew from $1.45B in 2025-Q1 to $2.41B in 2026-Q1, indicating progress towards the $9.61B full-year target. The trajectory shows delivering growth, aligning with management's guidance.
Guidance track record
Insufficient guidance history for this ticker.
Position context
— how violent might the path be while I hold it?Why this risk level
Recent vol — 30d annualized 43%; 252d 62%.
Drawdown — Max 1y −41%. Bad day move −4%.
Beta to sector ETF (XLK) — 0.08 over 1y.
Liquidity — score 100/100.
Sub-scores — vol 0/100, drawdown 18/100, beta 8/100, earnings vol —.
High uncertainty across multiple axes — fundamentals weak, management active, vol elevated.
via XLK
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive — historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only — describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-05-08.
What changed
The most important moves since the prior daily snapshot.
- No material changes since the prior snapshot.
No material changes since the prior snapshot.
as of 2026-05-08
Management scorecard
How management runs the business — capital, margins, balance sheet, and how reliably they guide and deliver.
Met or beat guidance 100% of the last 2 guided quarters · 727.5% avg surprise
What management is focused on
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
- #1
Accelerated share repurchase program
Capital allocationSynopsys announced a $250 million accelerated share repurchase agreement.
MixedNewly stated in 2026-Q1. Synopsys announced a $250 million accelerated share repurchase agreement. This is a new capital allocation initiative, and its impact on financials will be observed in future quarters.
44%CEO/CFO:“Synopsys announced an accelerated share repurchase agreement to repurchase $250 million of shares.”Press releaseSource dated 2026-03-02Stated 1 of last 8 quartersFirst seen 2026-03-02Show history (1)
- 2026-Q1Press release
“Synopsys announced an accelerated share repurchase agreement to repurchase $250 million of shares.”
- #2
Stock repurchase program authorization
Capital allocationSynopsys authorized a stock repurchase program of up to $2 billion.
On trackNewly stated in 2026-Q1. Synopsys authorized a stock repurchase program of up to $2 billion. This authorization provides flexibility for capital allocation, but its execution and impact on financials remain to be seen.
77%CEO/CFO:“The board authorized a stock repurchase program of up to $2 billion.”Press releaseSource dated 2026-02-25Stated 1 of last 8 quartersFirst seen 2026-02-25Show history (1)
- 2026-Q1Press release
“The board authorized a stock repurchase program of up to $2 billion.”
- #3
Revenue growth target for FY 2026
GrowthSynopsys targets full-year revenue of $9.61 billion at the midpoint for FY 2026.
MixedStated in 2 of last 2 quarters. Revenue grew from $1.45B in 2025-Q1 to $2.41B in 2026-Q1, indicating progress towards the $9.61B full-year target. The trajectory shows delivering growth, aligning with management's guidance.
65%CEO/CFO:“Reiterating expectations for full-year total revenue of $9.61 billion at the midpoint.”Press releaseSource dated 2026-02-25Stated 2 of last 8 quartersFirst seen 2026-02-25Show history (2)
- 2026-Q1Press release
“Reiterating expectations for full-year total revenue of $9.61 billion at the midpoint.”
- 2025-Q4Press release
“Expecting fiscal year 2026 revenue of $9.610 billion at mid-point.”
How this stock is priced
Two ways to read price: against peers in the same business, and against the company's own history.
Looks more expensive than peers.
Cheaper than its own typical valuation.
P/E over the last 5 years
71 monthly pointsHow this compares
A side-by-side read on composite, valuation, and risk versus peers.
| Stock | Composite | Valuation | Risk |
|---|---|---|---|
SNPS Synopsys | +8.4 | fair | high |
NVDA NVIDIA Corporation | +20 | full | moderate |
AAPL Apple Inc | +19 | full | moderate |
MSFT Microsoft | +27 | fair | elevated |
AVGO Broadcom | +11 | expensive | elevated |
Risk — how this stock moves
What a normal day looks like, what a bad day looks like, and the worst the last year has thrown at it.
What could change this view
Conditional scenarios — if X happens, the score would shift by about Y points. These are not predictions.
- If information_technology sector trend rises from +0.08 into 'improving' (>= +0.20)+5.0 pts
- If next-quarter guidance is raised (currently NEW as of 2026-02-25)+4.0 pts
- If next-quarter guidance is cut (currently NEW as of 2026-02-25)-8.0 pts
- If rates state reverses from -0.37 (negative) to +0.37 (positive)-7.3 pts
- If information_technology sector trend falls from +0.08 into 'weakening' (<= -0.20)-5.0 pts
Material updates
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
- 2026-04-2018d agoItem 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (e) Approval of Amended and Restated Equity Incentive Plan At the 2026 Annual Meeting of Stockholders (the “ Annual Meeting ”) of Synopsys, Inc. (“ Synopsys ”) held on April 16, 2026, Synopsys’ stockholders approved Synopsys’ Amended and Restated Equity Incentive Plan (the “ Equity Incentive Plan ”), in order to, among other things, include Synopsy…
executive changeneutralscore 37 - 2026-02-252mo agoItem 2.02
Results of Operations and Financial Condition. On February 25, 2026, Synopsys, Inc. (“ Synopsys ”, “ we ”, “ our ”, or “ us ”) issued a press release announcing the financial results of its first fiscal quarter ended January 31, 2026. A copy of the press release is furnished and attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto and incorporated by reference herein, shall not be de…
earnings preannouncementneutralscore 12 - 2026-03-022mo agoItem 8.01
Other Events. On March 2, 2026, Synopsys, Inc. (“ Synopsys ”) issued a press release announcing its entry into an accelerated share repurchase agreement with The Bank of Nova Scotia to repurchase an aggregate of $250 million of shares of Synopsys common stock. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
capital allocationpositivescore 11 - 2026-02-252mo agoItem 8.01
Other Events. On February 25, 2026, Synopsys also announced that its board of directors (the “ Board ”) replenished Synopsys’ existing stock repurchase program with authorization to purchase up to $2 billion of Synopsys common stock. The program authorizes, but does not obligate, Synopsys to purchase up to $2 billion of its common stock, and Synopsys’ chief executive officer, chief financial officer or Board may suspend or terminate the program at any time at their sole discretion.
capital allocationpositivescore 10 - 2026-02-192mo agoItem 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 14, 2026, in accordance with the applicable provisions of the amended and restated bylaws of Synopsys, Inc., a Delaware corporation (“ Synopsys ”), the Board of Directors (the “ Board ”) of Synopsys increased the size of the Board from eleven to twelve directors and appointed Peter A. Shimer to serve as a director and as a member of the…
executive changeneutralscore 9
Score history
The composite score, snapshot by snapshot. The dotted line at zero separates leaning-positive from leaning-negative.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.